- Globe Life (NYSE:GL) is set to announce its third-quarter 2026 financial results on October 21, with a conference call scheduled for October 22.
- Morgan Stanley recently adjusted its price target for Globe Life, lowering it to $197.00 from $208.00.
- Key valuation metrics for Globe Life include a trailing price-to-earnings ratio of 10.83, a price-to-sales ratio of 2.07, and an earnings yield of 9.38%.
Globe Life sells life insurance and supplemental health insurance, mainly to individuals and families. The insurance provider plans to release its third-quarter 2026 financial results after the market closes on October 21. Investors will be able to review the earnings report to see how its insurance business performs during the quarter.
Globe Life will hold a conference call on October 22 at 11 a.m. Eastern. The earnings release, supporting financial information, and a replay of the call will be available on its investor relations website.
Ahead of the Q3 2026 results, Morgan Stanley lowered its price target for Globe Life to $197.00 from $208.00. The stock traded at $165.25 when the update was published, about 19.20% below the new target. A price target is an analyst’s estimate of where a stock could trade, not a guaranteed price.
Globe Life has a trailing price-to-earnings ratio (P/E) of 10.83, meaning its stock price is about 10.83 times its earnings over the past year. Its price-to-sales ratio (P/S) is 2.07, and its earnings yield is 9.38%. These valuation metrics give investors ways to compare its share price with its sales and earnings performance.
